A whole body haplo-insufficient eIF4E+/− genetically engineered mouse model (GEMM) revealed that a “full dosage” of eIF4E is not required for normal development, yet it aids the translation of specific subsets of mRNAs, particularly those that regulate the production of reactive oxygen species, to promote tumour progression [154]. This evidence concerns the gene EIF4E and neoplasm.